Fortrea Holdings Inc. (FTRE) Presents at Citi Annual Global Healthcare Conference 2025 Transcript
Fortrea Holdings Inc. (FTRE) Presents at Citi Annual Global Healthcare Conference 2025 Transcript
Fortrea Holdings Inc. (FTRE) Q3 2025 Earnings Call Transcript
Fortrea Holdings Inc. ( FTRE ) Q3 2025 Earnings Call November 5, 2025 8:00 AM EST Company Participants Tracy Krumme - Senior VP of Investor Relations Anshul Thakral - CEO & Director Jill McConnell - Chief Financial Officer Conference Call Participants Eric Coldwell - Robert W. Baird & Co. Incorporated, Research Division David Windley - Jefferies LLC, Research Division Luke Sergott - Barclays Bank PLC, Research Division Justin Bowers - Deutsche Bank AG, Research Division Jenny Cao - Truist Securities, Inc., Research Division Alan Chen Presentation Operator Good day, and thank you for standing by.
Fortrea Holdings Inc. (FTRE) Q3 Earnings Lag Estimates
Fortrea Holdings Inc. (FTRE) came out with quarterly earnings of $0.12 per share, missing the Zacks Consensus Estimate of $0.16 per share. This compares to earnings of $0.23 per share a year ago.
Fortrea Holdings Inc. (FTRE) Q2 2025 Earnings Call Transcript
Fortrea Holdings Inc. (NASDAQ:FTRE ) Q2 2025 Earnings Conference Call August 6, 2025 8:00 AM ET Company Participants Anshul Thakral - Corporate Participant Hima B. Inguva - Head of Investor Relations & Corporate Development Jill McConnell - Chief Financial Officer Peter M.
Fortrea Holdings Inc. (FTRE) Beats Q2 Earnings and Revenue Estimates
Fortrea Holdings Inc. (FTRE) came out with quarterly earnings of $0.19 per share, beating the Zacks Consensus Estimate of $0.06 per share. This compares to a loss of $0.03 per share a year ago.
Fortrea Holdings: All Options Are On The Table
Fortrea Holdings Inc.'s operational and financial performance has deteriorated further, with missed improvement targets, declining sales, and mounting losses driving a 90% share price collapse. The company faces high leverage, negative earnings, and failed margin expansion, with debt restructuring and operational turnaround now critical for survival. Recent management changes and a shareholder rights plan signal efforts to protect FTRE investors amid takeover risks and ongoing business uncertainty.
FTRE vs. ILMN: Which Stock Should Value Investors Buy Now?
Investors interested in stocks from the Medical - Biomedical and Genetics sector have probably already heard of Fortrea Holdings Inc. (FTRE) and Illumina (ILMN). But which of these two stocks offers value investors a better bang for their buck right now?
Fortrea Holdings Inc. (FTRE) Q1 2025 Earnings Call Transcript
Fortrea Holdings Inc. (NASDAQ:FTRE ) Q1 2025 Earnings Conference Call May 12, 2025 9:00 AM ET Company Participants Hima Inguva - Head, Investor Relations and Corporate Development Tom Pike - Chief Executive Officer Jill McConnell - Chief Financial Officer Peter Neupert - Chairman and Interim CEO Conference Call Participants David Windley - Jefferies Justin Bowers - DB Patrick Donnelly - Citi Eric Coldwell - Baird Elizabeth Anderson - Evercore Charles Rhyee - TD Cowen Luke Sergott - Barclays Matt Sykes - Goldman Sachs Max Smock - William Blair Michael Ryskin - Bank of America Operator Ladies and gentlemen, thank you for standing by. And welcome to Fortrea First Quarter 2025 Earnings Conference Call.
Fortrea Holdings Inc. (FTRE) Q1 Earnings and Revenues Beat Estimates
Fortrea Holdings Inc. (FTRE) came out with quarterly earnings of $0.02 per share, beating the Zacks Consensus Estimate of a loss of $0.07 per share. This compares to loss of $0.04 per share a year ago.
Analysts Estimate Fortrea Holdings Inc. (FTRE) to Report a Decline in Earnings: What to Look Out for
Fortrea Holdings Inc. (FTRE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Fortrea: A Growing CRO With Strong Backlog, Margin Expansion, And Industry Tailwinds
FTRE's strong backlog of $7.7 billion provides revenue stability and planning advantages, despite short-term spin-off costs and missed earnings. The CRO market is projected to grow significantly, driven by increased outsourcing of complex late-stage trials, positioning FTRE for long-term growth. FTRE's global reach across 90 countries offers a competitive advantage in multi-region trials, enhancing patient enrollment and administrative efficiency.
Fortrea Holdings Inc. (FTRE) Q4 2024 Earnings Call Transcript
Fortrea Holdings Inc. (NASDAQ:FTRE ) Q4 2024 Earnings Call March 3, 2025 9:00 AM ET Company Participants Hima Inguva - Head, Investor Relations and Corporate Development Tom Pike - Chief Executive Officer Jill McConnell - Chief Financial Officer Conference Call Participants Patrick Donnelly - Citi Justin Bowers - DB David Windley - Jefferies Elizabeth Anderson - Evercore Luke Sergott - Barclays Eric Coldwell - Baird Max Smock - William Blair Will Ortmayer - Goldman Sachs Charles Rhyee - TD Cowen Michael Ryskin - Bank of America Operator Ladies and gentlemen, thank you for standing by, and welcome to Fortrea Fourth Quarter 2024 Earnings Conference Call. [Operator Instructions] Please be advised that today's conference is being recorded.
